Efficacy of linezolid alone or in combination with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 9, 2003, Pages 3002-3004

  Chiang, Fu Yu ^a   Climo, Michael ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b Neurology Service   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LINEZOLID; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIAL INFECTION; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MIXTURE; FEMALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ACETAMIDES; ANIMALS; ANTI-BACTERIAL AGENTS; AORTIC VALVE; COLONY COUNT, MICROBIAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; ENDOCARDITIS, BACTERIAL; FEMALE; KIDNEY; MACROLIDES; METHICILLIN RESISTANCE; OXAZOLIDINONES; RABBITS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN;

EID: 0042423638     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.9.3002-3004.2003     Document Type: Article

References (15)

1. Bayer, A. S., and K. Lam. 1985. Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations. J. Infect. Dis. 151:157-165.
2. Brandt, C. M., M. S. Rouse, B. M. Tallan, W. R. Wilson, and J. M. Steckelberg. 1994. Failure of time-kill synergy studies using subinhibitory antimicrobial concentrations to predict in vivo antagonism of cephalosporin-rifampin combinations against Staphylococcus aureus. Antimicrob. Agents Chemother. 38:2191-2193.
3. Clemett, D., and A. Markham. 2000. Linezolid. Drugs 59:815-827.
4. Climo, M. W., R. L. Patron, B. P. Goldstein, and G. L. Archer. 1998. Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis. Antimicrob. Agents Chemother. 42:1355-1360.
5. Dailey, C. F., C. L. Dileto-Fang, L. V. Buchanan, M. P. Oramas-Shirey, D. H. Batts, C. W. Ford, and J. K. Gibson. 2001. Efficacy of linezolid in treatment of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 45:2304-2308.
6. Fantin, B., and C. Carbon. 1992. In vivo antibiotic synergism: contribution of animal models. Antimicrob. Agents Chemother. 36:907-912.
7. Gerson, S. L., S. L. Kaplan, J. B. Bruss, V. Le, F. M. Arellano, B. Hafkin, and D. J. Kuter. 2002. Hematologic effects of linezolid: summary of clinical experience. Antimicrob. Agents Chemother. 46:2723-2726.
8. Miller, D., V. Urdaneta, A. Weltman, and S. Park. 2002. Public health dispatch: vancomycin-resistant Staphylococcus aureus - Pennsylvania, 2002. Morb. Mortal. Wkly. Rep. 51:902.
9. Oramas-Shirey, M. P., L. V. Buchanan, C. L. Dileto-Fang, C. F. Dailey, C. W. Ford, D. H. Batts, and J. K. Gibson. 2001. Efficacy of linezolid in a staphylococcal endocarditis rabbit model. J. Antimicrob. Chemother. 47:349-352.
10. Patel, R., K. E. Piper, M. S. Rouse, and J. M. Steckelberg. 2000. Linezolid therapy of Staphylococcus aureus experimental osteomyelitis. Antimicrob. Agents Chemother. 44:3438-3440.
11. Perlman, B. B., and L. R. Freedman. 1971. Experimental endocarditis. II. Staphylococcal infection of the aortic valve following placement of a polyethylene catheter in the left side of the heart. Yale J. Biol. Med. 44:206-213.
12. Rubinstein, E., S. Cammarata, T. Oliphant, and R. Wunderink. 2001. Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study. Clin. Infect. Dis. 32:402-412.
13. Sievert, D. M., M. L. Boulton, G. Stoltman, D. Johnson, M. G. Stobierski, F. P. Downes, P. A. Somsel, J. T. Rudrik, W. Brown, W. Hafeez, T. Lundstrom, E. Flanagan, R. Johnson, J. Mitchell, and S. Chang. 2002. Staphylococcus aureus resistant to vancomycin. Morb. Mortal. Wkly. Rep. 51:565-567.
14. Stevens, D. L., L. G. Smith, J. B. Bruss, M. A. McConnell-Martin, S. E. Duvall, W. M. Todd, and B. Hafkin. 2000. Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections. Antimicrob. Agents Chemother. 44:3408-3413.
15. Stevens, D. L., D. Herr, H. Lampiris, J. L. Hunt, D. H. Batts, and B. Hafkin. 2002. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Clin. Infect. Dis. 34:1481-1490.